
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.430 | 6.430 | 0.000 |
Shares | 94.140 | 94.140 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.150 | 25.621 |
Price to Book | 1.801 | 2.911 |
Price to Sales | 2.144 | 3.839 |
Price to Cash Flow | 13.537 | 17.269 |
Dividend Yield | 2.524 | 1.870 |
5 Years Earnings Growth | 7.054 | 5.563 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 95.950 | 95.762 |
Industrials | 2.020 | 0.510 |
Basic Materials | 0.850 | 0.926 |
Communication Services | 0.660 | 0.054 |
Technology | 0.510 | 0.701 |
Number of long holdings: 72
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 8.08 | 57.73 | +0.89% | |
WuXi AppTec | CNE1000031K4 | 6.20 | 81.02 | +2.80% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 5.43 | 217.06 | +1.12% | |
Yunnan Baiyao A | CNE0000008X7 | 4.77 | 56.21 | +0.54% | |
Raas Blood A | CNE100000C31 | 3.92 | 7.02 | +1.30% | |
Shanghai Fosun Pharm | CNE000000X38 | 3.91 | 26.40 | -0.04% | |
Changchun High A | CNE0000007J8 | 3.81 | 102.61 | +3.20% | |
Shanghai Pharm | CNE000000C82 | 3.40 | 19.18 | -0.16% | |
Walvax BioTech | CNE100000WN2 | 3.04 | 11.45 | +1.06% | |
Livzon Pharm A | CNE0000002Y8 | 3.01 | 42.24 | -0.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Changxin Jinli Trend Stock Fund | 6.41B | 3.78 | -1.86 | 5.97 | ||
Changxin Quant Gr Strat Eq A | 1.08B | 2.84 | -4.53 | - | ||
Changxin Quantified Pioneer Stock F | 592.78M | 8.10 | -6.70 | 1.25 | ||
Changxin Domestic Demand Growth St | 572.45M | -3.48 | -3.30 | 4.40 | ||
Changxin Ruijin Alloc A | 357.08M | 3.57 | -7.33 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review